Chronic Immune-Mediated Diarrhea and Colitis Associated With Prolonged Survival in Patients Treated With ICIs
The immune-related AE, immune-mediated diarrhea and colitis, can have a limited course or may exist for long-term periods.
The immune-related AE, immune-mediated diarrhea and colitis, can have a limited course or may exist for long-term periods.
Investigators describe the steps taken to improve clinician referrals to the facility’s outpatient rehabilitation program for patients with GI cancers.
The “watch and wait” approach is characterized by close surveillance without surgery in patients with rectal cancer who achieve a clinical CR following neoadjuvant CRT.
Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.
Results of this study showed no improvement in the rate of 30-day hospital readmission for patients with cancer undergoing pancreatectomy between 2005 and 2011.
In this study, a young adult was defined as an individual who was 40 years or younger.
In this study, patients were randomly assigned to receive standard-dose RT or standard-dose RT plus an integrated RT boost to the primary tumor.
In this study, deterioration in specific PROs required a drop of at least 10 points from baseline.
Fewer treatment-related grade 3 or higher adverse events were reported in the avelumab arm compared with the chemotherapy arm.
The randomized, phase 3 BEACON CRC trial was a 3-arm study conducted in patients with pretreated metastatic CRC characterized by a BRAF V600E mutation.